Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications

Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications

Objectives: Adrenocortical scintigraphy for patients with primary aldosteronism (PA) without discontinuation or modification of antihypertensive medications is of concern because of drug interference with the renin–angiotensin–aldosterone system. We report the surgical outcomes of patients with PA l...

Full description

Bibliographic Details
Main Authors: Chia-Hui Chang, Stephen Shei-Dei Yang, Yao-Chou Tsai, Shi-Wen Kuo, Shiou-Chi Cherng, Ching-Chu Lu, Ruoh-Fang Yen, Vin-Cent Wu, Ya-Hui Hu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Tzu-Chi Medical Journal
Subjects:
Adrenocortical scintigraphy
Drug discontinuation
I-131-6 β-iodomethyl-norcholesterol single photon emission computed tomography/computed tomography
Primary aldosteronism
Spironolactone
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2018;volume=30;issue=3;spage=169;epage=175;aulast=Chang

Internet

http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2018;volume=30;issue=3;spage=169;epage=175;aulast=Chang

Similar Items